Stock Taper
SCREENER COMPARE ANY 2 STOCKS
CERS
CERUS CORPORATION
NASDAQ
$2.65
▼ DOWN 2.57% (-0.07)

KEY STATISTICS

Market Cap$534.04 M
52w High$3.47
52w Low$1.17
Dividend Yield—
Frequency—
P/E-52.89
Volume1.68M
Shares Out.201.52M

COMPANY

LEADERSHIP

Vivek K. Jayaraman
CHIEF EXECUTIVE
Vivek K. Jayaraman

COMPENSATION 2026

Salary$793,750
Stock Awards$2,242,585
Incentive Plan Pay$756,000
All Other Comp.$2,322
Total$3,794,657

ABOUT

SECTOR
Healthcare
WENT PUBLIC
January 31, 1997
METHOD OF GOING PUBLIC
IPO
FULL TIME EMPLOYEES
268

PRICE TARGET

Target High$4.00
Target Low$4.00
Target Median$4.00
Target Consensus$4.00

UPCOMING EARNINGS

DateNov 5, 2026
DayThursday
Rev. Est.$63.25M
NOV
5
THU

PRICE

$2.65 ▼ DOWN 2.57% (−$0.07)
$2.65$2.68$2.70$2.739:30 AM10:35 AM11:40 AM12:45 PM1:49 PM2:54 PM3:59 PM2.65

About Cerus Corporation

https://www.cerus.com ↗

Cerus Corporation develops and commercializes the INTERCEPT Blood System to inactivate pathogens in blood components, enhancing transfusion safety worldwide.

INDUSTRY

Medical - Devices

A PRODUCT CERUS CORPORATION IS KNOWN FOR

INTERCEPT Blood System
INTERCEPT Blood System

The INTERCEPT Blood System is a leading pathogen reduction technology that inactivates viruses, bacteria, and parasites in blood components like platelets and plasma to ensure a safer global blood supply.

COMPETITORS

COMPETITOR
AEMD COMPARE
CTSO COMPARE
GRFS COMPARE
HAE COMPARE

Revenue by Products

IconPRODUCTQ3-2025Q4-2025Q1-2026Q2-2026
Product$52.7M $57.75M ▲$53.66M ▼$57.44M ▲
Government Contract$7.54M $12.44M ▲— —

Revenue by Geography

MapREGIONQ2-2025Q3-2025Q1-2026Q2-2026
North America$35.29M $35.03M ▼$36.76M ▲$38.36M ▲
Europe Middle East and Africa$16.61M $16.74M ▲$15.68M ▼$18.34M ▲
Other$547K $923K ▲$1.23M ▲$749K ▼

ETFS HOLDING THIS STOCK

ETFS HOLDING
73
LISTED HERE
15
RANKED BY POSITION SIZE
ARKK
0.36% · 8.8M
VTS.AX
0.00% · 6.1M
XSU.TO
0.02% · 5.1M
FESM
0.07% · 1.6M
SCHA
0.01% · 954.6K
R2SC.L
0.02% · 367.9K
GSSC
0.08% · 339.2K
FSML
0.52% · 288.9K
PSC
0.02% · 210.2K
XRSU.L
0.02% · 182.0K
PRFZ
0.02% · 175.4K
RSSL
0.02% · 94.5K
URTY
0.01% · 8.1K
RESM
0.02% · 555
FVI
0.01% · 407

INSTITUTIONAL OWNERSHIP

SHARES OWNED
60.01%
HOLDERS
273
TOP 12 OF 273 · RANKED BY POSITION SIZE
Blackrock, Inc.
22.2M sh · $64.87M
Ark Investment Management LLC
19.2M sh · $34.87M
Blackrock Inc.
13.9M sh · $24.45M
Vanguard Group Inc
11.2M sh · $23M
Soleus Capital Management, L.P.
10.8M sh · $19.57M
Baker Bros. Advisors LP
10.0M sh · $18.22M
Elk Creek Partners, LLC
6.2M sh · $29M
Sumitomo Mitsui Trust Holdings, Inc.
5.7M sh · $9.04M
Nikko Asset Management Americas, Inc.
5.7M sh · $9.04M
Wasatch Advisors LP
5.5M sh · $8.81M
D. E. Shaw & Co., Inc.
5.5M sh · $16.02M
Geode Capital Management, LLC
5.1M sh · $14.95M

RATINGS SNAPSHOT

Overall rating: C

DCFROEROAD/EP/EP/B
Discounted Cash Flow5
Return On Equity1
Return On Assets1
Debt To Equity1
Price To Earnings1
Price To Book1
Overall Score2

INSIDER TRADES

★
OFFICER: CHIEF LEGAL OFFICER
Jensen Chrystal
Sale · 30.0K shares
2026-08-17
★
OFFICER: CHIEF EXECUTIVE OFFICER
Jayaraman Vivek K
Sale · 16.7K shares
2026-07-16
★
OFFICER: CHIEF OPERATING OFFICER
Jayaraman Vivek K
Sale · 42.4K shares
2026-06-30
★
OFFICER: CHIEF OPERATING OFFICER
Jayaraman Vivek K
Purchase · 369.7K shares
2026-07-01

MOST RECENT ANALYST GRADES

GRADE SUMMARY
BUY 1
1 GRADES IN THE LAST 12 MONTHS
BTIG BUY

SECTORS PEERS

PEERPRICE
NPCE$14.41COMPARE
SGHT$8.55COMPARE
MASS$10.73COMPARE
SENS$9.33COMPARE
TKNO$7.12COMPARE
RXST$7.05COMPARE
QTRX$2.64COMPARE
CVRX$2.95COMPARE